These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 16129214

  • 1. Time profiles of peritoneal and renal clearances of different uremic solutes in incident peritoneal dialysis patients.
    Bammens B, Evenepoel P, Verbeke K, Vanrenterghem Y.
    Am J Kidney Dis; 2005 Sep; 46(3):512-9. PubMed ID: 16129214
    [Abstract] [Full Text] [Related]

  • 2. High correlation between clearance of renal protein-bound uremic toxins (indoxyl sulfate and p-cresyl sulfate) and renal water-soluble toxins in peritoneal dialysis patients.
    Huang WH, Hung CC, Yang CW, Huang JY.
    Ther Apher Dial; 2012 Aug; 16(4):361-7. PubMed ID: 22817125
    [Abstract] [Full Text] [Related]

  • 3. Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms.
    Bammens B, Evenepoel P, Verbeke K, Vanrenterghem Y.
    Kidney Int; 2003 Dec; 64(6):2238-43. PubMed ID: 14633148
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effectiveness of furosemide in patients on peritoneal dialysis.
    Flinn A, Ledger S, Blake P.
    CANNT J; 2006 Dec; 16(3):40-4. PubMed ID: 17061696
    [Abstract] [Full Text] [Related]

  • 7. Long-term follow-up of body size indices, residual renal function, and peritoneal transport characteristics in continuous ambulatory peritoneal dialysis.
    Twardowski ZJ, Moore HL, Prowant BF, Satalowich R.
    Adv Perit Dial; 2009 Dec; 25():155-64. PubMed ID: 19886338
    [Abstract] [Full Text] [Related]

  • 8. Superior dialytic clearance of beta(2)-microglobulin and p-cresol by high-flux hemodialysis as compared to peritoneal dialysis.
    Evenepoel P, Bammens B, Verbeke K, Vanrenterghem Y.
    Kidney Int; 2006 Aug; 70(4):794-9. PubMed ID: 16820785
    [Abstract] [Full Text] [Related]

  • 9. Effect of iodinated contrast agents on residual renal function in PD patients.
    Moranne O, Willoteaux S, Pagniez D, Dequiedt P, Boulanger E.
    Nephrol Dial Transplant; 2006 Apr; 21(4):1040-5. PubMed ID: 16352623
    [Abstract] [Full Text] [Related]

  • 10. Dialysis adequacy, residual renal function and serum concentrations of selected low molecular weight proteins in patients undergoing continuous ambulatory peritoneal dialysis.
    Stompór T, Sułowicz W, Anyszek T, Kuśnierz B, Fedak D, Naskalski JW.
    Med Sci Monit; 2003 Nov; 9(11):CR500-4. PubMed ID: 14586277
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Small-solute and middle-molecule clearances during continuous flow peritoneal dialysis.
    Leypoldt JK, Burkart JM.
    Adv Perit Dial; 2002 Nov; 18():26-31. PubMed ID: 12402582
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Better preservation of residual renal function in peritoneal dialysis patients treated with a low-protein diet supplemented with keto acids: a prospective, randomized trial.
    Jiang N, Qian J, Sun W, Lin A, Cao L, Wang Q, Ni Z, Wan Y, Linholm B, Axelsson J, Yao Q.
    Nephrol Dial Transplant; 2009 Aug; 24(8):2551-8. PubMed ID: 19258386
    [Abstract] [Full Text] [Related]

  • 15. Low-GDP fluid (Gambrosol trio) attenuates decline of residual renal function in PD patients: a prospective randomized study.
    Haag-Weber M, Krämer R, Haake R, Islam MS, Prischl F, Haug U, Nabut JL, Deppisch R, behalf of the DIUREST Study Group.
    Nephrol Dial Transplant; 2010 Jul; 25(7):2288-96. PubMed ID: 20197284
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters.
    Rodrigues AS, Martins M, Korevaar JC, Silva S, Oliveira JC, Cabrita A, Castro e Melo J, Krediet RT.
    Am J Nephrol; 2007 Jul; 27(1):84-91. PubMed ID: 17284895
    [Abstract] [Full Text] [Related]

  • 17. Contribution of tubular anion and cation secretion to residual renal function in chronic dialysis patients.
    van Olden RW, van Acker BA, Koomen GC, Krediet RT, Arisz L.
    Clin Nephrol; 1998 Mar; 49(3):167-72. PubMed ID: 9543598
    [Abstract] [Full Text] [Related]

  • 18. Peritoneal dialysis patient survival: a comparison between a Swedish and a Korean centre.
    Chung SH, Heimbürger O, Lindholm B, Lee HB.
    Nephrol Dial Transplant; 2005 Jun; 20(6):1207-13. PubMed ID: 15784640
    [Abstract] [Full Text] [Related]

  • 19. Hyperphosphatemia in Chinese peritoneal dialysis patients with and without residual kidney function: what are the implications?
    Wang AY, Woo J, Sea MM, Law MC, Lui SF, Li PK.
    Am J Kidney Dis; 2004 Apr; 43(4):712-20. PubMed ID: 15042549
    [Abstract] [Full Text] [Related]

  • 20. Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study.
    Kim S, Oh J, Kim S, Chung W, Ahn C, Kim SG, Oh KH.
    Nephrol Dial Transplant; 2009 Sep; 24(9):2899-908. PubMed ID: 19258384
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.